Changes in the Gastrointestinal Microbiota Induced by Proton Pump Inhibitors-A Review of Findings from Experimental TrialsMICROORGANISMSIF4.22024-05-301OAAI
The ileal fungal microbiota is altered in Crohn's disease and is associated with the disease courseFRONTIERS IN MEDICINEIF32022-09-2710OAAI
Factors associated with the persistence of oral 5-aminosalicylic acid monotherapy in ulcerative colitis: a nationwide Norwegian cohort studyTHERAPEUTIC ADVANCES IN GASTROENTEROLOGYIF3.42021-06-282OAAI
Editorial: mesalamine and mucosal microbiome in quiescent ulcerative colitis-what can we learn? Authors' replyALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72019-05-270OAAI
Mucosal 5-aminosalicylic acid concentration, drug formulation and mucosal microbiome in patients with quiescent ulcerative colitisALIMENTARY PHARMACOLOGY & THERAPEUTICSIF6.72019-03-2032OAAI
Mucosal 5-ASA concentration is associated with changes in mucosal bacterial microbiome diversity and composition in patients with quiescent ulcerative colitisJOURNAL OF CROHNS & COLITISIF8.72019-01-250OAAI